ASX health sector down in topsy turvy week
ASX heath sector falls 2.1%, while broader markets rise 0.8% for the same period Opthea phase III Coast trial into wet AMD fails to meet primary and secondary endpoints EMVision starts pivotal validation trial for emu bedside brain scanner to diagnose …